Genetic Analysis and Ferring Pharmaceuticals Announce A Collaboration To Develop A New Microbiome Rapid Diagnostic Test 2024-12-262024-12-20
Genetic Analysis publishes information memorandum relating to the previously announced subsequent offering 2023-12-112023-12-08
Genetic Analysis announces final number of subscription rights received per existing share in the previously announced subsequent offering 2023-12-08
Genetic Analysis announces terms of the previously announced subsequent offering to shareholders of up to appr. NOK 9 million 2023-11-30
